Clinical Trials Logo

Clinical Trial Summary

This is a long term safety study of DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines following single and repeat administration.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03004248
Study type Interventional
Source Revance Therapeutics, Inc.
Contact
Status Completed
Phase Phase 3
Start date December 9, 2016
Completion date October 17, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02236312 - Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines Phase 2
Completed NCT00430963 - IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines Phase 3
Completed NCT03687736 - Subject Satisfaction With AbobutulinumtoxinA Treatment Phase 4
Active, not recruiting NCT04281745 - Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX® Phase 4
Active, not recruiting NCT03440671 - The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines Phase 3
Completed NCT03736928 - Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines Phase 2
Completed NCT01808742 - Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device N/A
Completed NCT01485601 - Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines Phase 2
Completed NCT00777803 - NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines Phase 3
Completed NCT00430586 - Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines Phase 2
Completed NCT04281095 - A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines Phase 1/Phase 2
Completed NCT02428608 - Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006 Phase 2
Completed NCT04143815 - Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines Phase 2
Completed NCT01333397 - Safety and Efficacy Study of Dysport RU and Glabellar Lines Phase 2
Active, not recruiting NCT04830345 - Phase 3 Study to Compare the Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines Phase 3
Completed NCT01391312 - Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines Phase 4
Completed NCT03960957 - Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines Phase 3
Completed NCT01391299 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines N/A
Not yet recruiting NCT04715048 - Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines Early Phase 1
Completed NCT02334436 - A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 Phase 3